Skip to main content
SpringerLink
Log in

Renin-Angiotensin System Proteases and the Cardiometabolic Syndrome: Pathophysiological, Clinical and Therapeutic Implications

  • Chapter
Frontiers in Research of the Renin-Angiotensin System on Human Disease

Part of the book series: Proteases in Biology and Disease ((PBAD,volume 7))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abuissa H, Jones PG, Marso SP, O’Keefe JH Jr, 2005, Angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 46: 821–826

    Article  PubMed  CAS  Google Scholar 

  • Aguilera G, Kapur S, Feuillan P, Sunar-Akbasak B, Bathia AJ, 1994, Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney. Kidney Intl. 46: 973–979

    Article  CAS  Google Scholar 

  • Albu JB, Kovera AJ, Johnson JA, 2000. Fat distribution in health and obesity. Ann N.Y. Acad Sci. 904: 491–501

    Article  PubMed  CAS  Google Scholar 

  • Alexander CM, Landsman PB, Teutsch SM, Haffner SM, 2003, NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of coronary artery disease among NHANES III participants age 50 years and older. Diabetes. 52: 1210–1214

    Article  PubMed  CAS  Google Scholar 

  • Allen AM, Zhuo JL, 1999, Mendelsohn FAO. Localization of angiotensin II AT1 and AT2 receptors. J Am Soc Nephrol. 10: S23–S29

    PubMed  CAS  Google Scholar 

  • Aneja A, El-Atat F, McFarlane SI, Sowers JR, 2004, Hypertension and obesity. Recent Prog Horm Res. 59: 169–205

    Article  PubMed  CAS  Google Scholar 

  • Avogaro P, Crepaldi G, Enzi G, Tiengo A, 1967, Associazione di hiperlipidemia diabete mellito e obesita di medio grado. Acta Diabetol Lat. 4: 36–41

    Article  Google Scholar 

  • Bays H, Mandarino L, De Fronzo R, 2004, Role of the adipocyte, free fatty acids and ectopic fat in the pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferators-activated receptor agonists provide a rationale therapeutic approach. J Clin Endocrinol Metab. 89: 463–478

    Article  PubMed  CAS  Google Scholar 

  • Bergman RN, Van Citters GW, Mittelman SD, et al 2001, Central role of the adipocyte in the Metabolic Syndrome. J Investig Med. 49: 119–126

    Article  PubMed  CAS  Google Scholar 

  • Berk BC, Corson MA, 1999, Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res. 80: 607–616

    Google Scholar 

  • Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG, 2001, Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol. 281: H2337–H2365

    PubMed  CAS  Google Scholar 

  • Blundell T, Sibanda BLK, Pearl L, 1983, Three dimensional structure, specificity and catalytic mechanism of renin. Nature. 304: 273–275

    Article  PubMed  CAS  Google Scholar 

  • Booz GW, Baker KM, 1996, Role of type 1 and type 2 angiotensin receptors in angiotensin II – induced cardiomyocyte hypertrophy. Hypertension. 28: 635–640

    PubMed  CAS  Google Scholar 

  • Brink M, Welen J, Delafontaine P, 1996, Angiotensin II causes weight loss and decreases Insulin-Like Growth Factor in rats through a pressor-independent mechanism. J Clin Invest. 97: 2509–2516

    PubMed  CAS  Google Scholar 

  • Bunning P, Holmquist B, Riordan JF, 1983, Substrate, specificity and kinetic characteristics of angiotensin converting enzyme. Biochemistry. 22: 103–110

    Article  PubMed  CAS  Google Scholar 

  • Burson JM, Aguilera G, Gross KW, Sigmund CD, 1994, Differential expression of angiotensin receptor 1A and 1B in mouse. Am J Physiol Endocrinol Metab. 267: E260–E267

    CAS  Google Scholar 

  • Carey RM, Siragy HM, 2003, Newly recognized components of the Renin-Angiotensin System: Potential Roles in cardiovascular and renal regulation. Endocrine Reviews. 24: 261–271

    Article  PubMed  CAS  Google Scholar 

  • Carlsson PO, Berne C, Jansson L, 1998, Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats. Diabetologia. 41: 127–133

    Article  PubMed  CAS  Google Scholar 

  • Cassis LA, 1993, Role of angiotensin II in brown adipose thermogenesis during cold acclimation. Am J Physiol Endocrinol Metab. 265: E680–E685

    Google Scholar 

  • Cassis LA, English VL, Bharadwaj K, Boustany CM, 2004, Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology. 145: 169–174

    Article  PubMed  CAS  Google Scholar 

  • Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA, 1998, Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol Endocrinol Metab. 274: 867–876

    Google Scholar 

  • Chu KY, Lau T, Carlsson P, Leung PS, 2006, Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes. 55: 367–374

    Article  PubMed  CAS  Google Scholar 

  • Crackower MA, Sarao R, Oudit GY, et al 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 417: 822–828

    Article  PubMed  CAS  Google Scholar 

  • Crandall DL, Armellino DC, Busler DE, Mc Hendry-Rinde B, Kral JG, 1999, Angiotensin II receptor in human preadipocytes: role in cell cycle regulation. Endocrinology. 140: 154–158

    Article  PubMed  CAS  Google Scholar 

  • Crandall DL, Herzlinger HE, Saunders BD, Armellino DC, Kral JG, 1994, Distribution of angiotensin receptors in rat and human adipocytes. J Lipid Res. 35: 1378–1385

    PubMed  CAS  Google Scholar 

  • Dickson ME, Sigmund CD, 2006, Genetic basis of hypertension: revisiting Angiotensinogen. Hypertension. 48: 14–20

    Article  PubMed  CAS  Google Scholar 

  • Duncan GE, Sierra ML, Zhou XH, 2004, Prevalence and trends of a Metabolic Syndrome phenotype among U.S. adolescents, 1999–2000. Diabetes Care. 27: 2438–2443

    Article  PubMed  Google Scholar 

  • Engeli S, Negrel R, Sharma AM, 2000, Physiology of the adipose tissue renin-angiotensin system. Hypertension. 35: 1270–1277

    PubMed  CAS  Google Scholar 

  • Fernández-Real JM, Ricart W, 2003, Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Reviews. 24: 278–301

    Article  PubMed  CAS  Google Scholar 

  • Flegal KM, Carroll MD, Ogden CL, et al 2002, Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 288: 1723–1727

    Article  PubMed  Google Scholar 

  • Ford ES, 2005, Prevalence of the Metabolic Syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care. 28: 2745–2749

    Article  PubMed  Google Scholar 

  • Frederich RC, Kahn BB, Peach MJ, Flier JS, 1992, Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension. 19: 339–344

    PubMed  CAS  Google Scholar 

  • Giacchetti G, Sechi LA, Rilli S, Carey RM, 2005, The renin angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab. 16 (3): 120–126

    Article  PubMed  CAS  Google Scholar 

  • Goldstein BJ, Scalia R, 2004, Adiponectin: A novel Adipokyne linking adipocytes and vascular function. Journal of Clinical Endocrinology and Metabolism. 89: 2563–2568

    Article  PubMed  CAS  Google Scholar 

  • Goodpaster BH, Krishnaswami S, Harris TB, et al 2005, Obesity, regional body fat distribution, and the Metabolic Syndrome in older men and women. Arch Intern Med. 165: 777–783

    Article  PubMed  Google Scholar 

  • Goodpaster BH, Thaete FL, Kelley DE, 2000, Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr. 71: 885–892

    PubMed  CAS  Google Scholar 

  • Govindarajan G, Eble DM, Lucchesi PA, Samarel AM, 2000, Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured smooth vascular cells. Circ Res. 87: 710–716

    PubMed  CAS  Google Scholar 

  • Griendling KK, Murphy TJ, Alexander RW, 1993, Molecular Biology of the rennin-angiotensin system. Circulation. 87: 1816–1828

    PubMed  CAS  Google Scholar 

  • Hansson L, Lindholm LH, Niskanen L, et al 1999, Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. Lancet. 353: 611–6

    Article  PubMed  CAS  Google Scholar 

  • Hardie DG, 2004, The AMP-activated protein kinase pathway - New players upstream and downstream. J Cell Sci. 117: 5479–5487

    Article  PubMed  CAS  Google Scholar 

  • Heart Outcomes Prevention Evaluation Study Investigators, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342: 145–153

    Google Scholar 

  • Hirochi M, Hayashida W, Akishita M, et al 1999, Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative cross talk. Circ Res. 84: 876–882

    Google Scholar 

  • Hjorth SA, Schambye HT, Greenlee WJ, Schwartz TW, 1994, Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J Biol Chem. 269: 30953–30959

    PubMed  CAS  Google Scholar 

  • Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ, 1997, Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activating protein kinase phosphatase-1 and induces apoptosis. J Biol Chem. 272: 19022–19026

    Article  PubMed  CAS  Google Scholar 

  • Hotamisligil GS, Spiegelman BM, 1994, Tumor necrosis factor a: a key component of the obesity-diabetes link. Diabetes. 43: 1271–1278

    Article  PubMed  CAS  Google Scholar 

  • Huang XC, Richards EM, Sumners C, 1996, Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem. 271: 15635–15641

    Article  PubMed  CAS  Google Scholar 

  • James PT, Leach R, Kalamara E, Shayeghi M, 2001, The Worldwide obesity epidemic. Obes Res. 9: 228S–233S

    PubMed  Google Scholar 

  • Jones BH, Stanridge MK, Moustaid N, 1997, Angiotensin II increased lipogenesis in 3T3-L1 and human adipose cells. Endocrinology. 138: 1512–1519

    Article  PubMed  CAS  Google Scholar 

  • Julius S, Kjeldsen SE Webel, M, et al 2004, Outcomes in hypertensives patients at high risk of cardiovascular risk treated with regimens based on valsartan and amlodipine: the VALUE randomized trial. Lancet. 363: 2022–2231

    Article  PubMed  CAS  Google Scholar 

  • Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K, 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 116: 1784–1792

    Article  PubMed  CAS  Google Scholar 

  • Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, Carlsson MS, 1998, Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to Angiotensin II. J Clin Endocrinol Metab. 83: 3925–3929

    Article  PubMed  CAS  Google Scholar 

  • Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, Son HY, Kim MJ, Jeong IK, Yoon KH, 2006, High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem. 98: 343–55

    Article  PubMed  CAS  Google Scholar 

  • Konishi H, Kuroda S, Inada Y, Fujisawa Y, 1994, Novel subtype of human angiotensin II type 1 receptor: cDNA cloning and expression. Biochem Biophys Res Commun. 199: 467–474

    Article  PubMed  CAS  Google Scholar 

  • Konoshita T, et al 2006, Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care. 29: 848–52

    Article  PubMed  CAS  Google Scholar 

  • Kristiansen OP, Mandrup-Poulse T, 2005, Interleukin-6 and Diabetes: The good, the bad, or the indifferent? Diabetes. 54 (Suppl 2): S114–S124

    Article  PubMed  CAS  Google Scholar 

  • Krssak M, Falk Petersen K, Dresner A, et al 1999, Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia. 42: 113–116

    Article  PubMed  CAS  Google Scholar 

  • Lam KY, Leung PS, 2002, Regulation and expression of a rennin-angiotensin system in human pancreas and pancreatic endocrine tumors. Eur J Endocrinol, 146: 567–572

    Article  PubMed  CAS  Google Scholar 

  • Lau T, Carlsson PO, Leung PS, 2004, Evidence for a local angiotensin system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia. 47: 240–248

    Article  PubMed  CAS  Google Scholar 

  • Lastra G, Manrique C, Sowers, JR, 2006, Obesity and chronic kidney disease: The weight of the evidence. Adv Chronic Kidney Dis. 13: 365–373

    Article  PubMed  Google Scholar 

  • Leung PS, Carlsson PO, 2001, Tissue renin-angiotensin system: its expression, localization, regulation and potential role in the pancreas. J Mol Endocrinol. 26: 155–164

    Article  PubMed  CAS  Google Scholar 

  • Leung PS, Chappell MC, 2003, A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol. 35: 838–846

    Article  PubMed  CAS  Google Scholar 

  • Licata G, Scaglione R, Ganguzza A, et al 1994, Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens. 7: 314–320

    PubMed  CAS  Google Scholar 

  • Lorenzo O, Ruiz-Ortega M, Suzuki Y, et al 2002, Angiotensin III Activates Nuclear Transcription Factor-kB in Cultured Mesangial Cells Mainly via AT2 Receptors: Studies with AT1 Receptor-Knockout Mice. J. Am. Soc. Nephrol. 13: 1162

    Article  PubMed  CAS  Google Scholar 

  • Lorenzo, C, Serrano-Rios M, Martinez-Larrad MT, et al 2006, Geographic variations of the International Diabetes Federation anf the National Cholesterol Education Program – Adult Treatment Panel III Definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care. 29: 685–691

    Article  PubMed  Google Scholar 

  • Lupi et al 2006, The direct effects of the angiotensin converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets. Eur J of Endocrinol. 154: 355–361

    Article  CAS  Google Scholar 

  • Madrid MI, Garcia-Duran M, Tornel J, De Gasparo M, Fenoy FJ, 1997, Effect of interactions between nitric oxide and angiotensin II on pressure natriuresis. Am J Physiol Regulatory Integrative Comp Physiol. 273: R1676–R1682

    CAS  Google Scholar 

  • Manrique C, Lastra G. Sowers JR, 2005, Hypertension and the Cardiometabolic Syndrome. Journal of Clinical Hypertension. 7: 471–476

    Article  PubMed  Google Scholar 

  • Massiera F, Bloch-Faure M, Ceiler D, et al 2001, Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 15: 2727–2729

    PubMed  CAS  Google Scholar 

  • Navar LG, 2004, The intrarenal renin-angiotensin system in hypertension. Kidney Intl. 65: 1522–1532

    Article  Google Scholar 

  • Nguyen G, Bouzhir L, Delarue F, Rondeau E, Giller T, Sraer JD, 2002, Pivotal role of the renin/Prorenin receptor in Angiotensin II production and cellular responses to Renin. J Clin Invest. 109: 1417–1427

    Article  PubMed  CAS  Google Scholar 

  • Nickenig G, Harrison DG, 2002, The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part I: Oxidative stress and atherogenesis. Circulation. 105: 393–396

    Article  PubMed  CAS  Google Scholar 

  • Nickenig G, Ostergren J, Struijke-Boudier H, 2006, Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers. JRAAS. 7: S1–S7

    PubMed  CAS  Google Scholar 

  • Ouchi N, Ohishi M, Kihara S, et al 2003, Association of hypoadiponectinemia with impaired vasoreactivity. Journal of Hypertension. 42: 231–234

    Article  CAS  Google Scholar 

  • Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, Carey RM, 1997, Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension. 30: 1238–1246

    PubMed  CAS  Google Scholar 

  • Pagano PJ, Chanock SJ, Siwik DA, Colucci WS, Clark JK, 1998, Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension. 32: 331–337

    PubMed  CAS  Google Scholar 

  • Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, 2003, The metabolic syndrome: Prevalence and risk factor findings in the US population from the third national health and nutrition examination survey, 1988 1994. Arch Int Med. 163: 427–436

    Article  Google Scholar 

  • Paula RD, Lima CV, Khosla MC, 1995, Angiotensin (1–7) potentiates hypotensive effect of bradykinin in conscious rats. Hypertension. 26: 1154–1159

    PubMed  CAS  Google Scholar 

  • Peach MJ, 1977, Renin-angiotensin system: Biochemistry and mechanisms of action. Physiol Rev. 57: 313–370

    PubMed  CAS  Google Scholar 

  • Pickup JC, 2004, Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 27: 813–823

    Article  PubMed  Google Scholar 

  • Pittas AG, Joseph NA, Greenberg AS, 2004, Adipocytokines and insulin resistance. J Clin Endocrinol Metab. 89: 447–452

    Article  PubMed  CAS  Google Scholar 

  • Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal J, Michel J, 2000, Angiotensin II stimulates endothelial vascular cell adhesion molecule – 1 via nuclear factor κB activation induced by intracellular oxidative stress. Arterioscler thromb Vasc Biol. 20: 645–654

    PubMed  CAS  Google Scholar 

  • Ran J, Hirano T, Adachi M, 2004, Angiotensin II type 1 receptor b locker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am J Physiol Endocrinol Metab. 287: E227–E232

    Article  PubMed  CAS  Google Scholar 

  • Ravussin E, Smith SR, 2002, Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance and type 2 diabetes mellitus. Ann N.Y. Acad Sci. 967: 363–378

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Vita J, Sanchez-Lopez E, Esteban V, Ruperez M, Egido J, Ruiz-Ortega M, 2005, Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation. 111: 2509–2517

    Article  PubMed  CAS  Google Scholar 

  • Ruiz-Ortega M, Lorenzo O, Ruperez M, et al 2001, Systemic infusion of angiotensin II into normal rats activates nuclear factor κ-B and AP-1 in the kidney. Role of AT1 and AT2 receptors. Am J Pathol. 158: 1743–175

    PubMed  CAS  Google Scholar 

  • Ruiz-Ortega M, Lorenzo O, Ruperez M, Kong S, Wittig B, Egido J, 2000, Angiotensin II activates nuclear transcription factor kB through AT1 and At2 in vascular smooth cells: molecular mechanisms. Circ Res. 86: 1266–1272

    PubMed  CAS  Google Scholar 

  • Sadoshima J, 2000, Cytokine actions of angiotensin II. Circ Res. 86: 1187–1189

    PubMed  CAS  Google Scholar 

  • Safonova I, Aubert J, Negrel R, Ailhaud G, 1997, Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J. 322 (Pt 1): 235–239

    PubMed  CAS  Google Scholar 

  • Saward L, Zahradka P, 1997, Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth cells. Circ Res. 81: 249–25

    PubMed  CAS  Google Scholar 

  • Schneider BS, Faust IM, Hemmes R, Hirsch J, 1981, Effects of altered adipose tissue morphology on plasma insulin levels in the rat. Am J Physiol. 240: E358–E362

    PubMed  CAS  Google Scholar 

  • Senn JJ, Klover PJ, Nowak IA, et al 2003, Suppressor of Cytokine Signaling – 3 (SOCS-3), a potential mediator of Interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem. 278: 13740–13746

    Article  PubMed  CAS  Google Scholar 

  • Sowers JR, 2002, Hypertension, angiotensin II and oxidative stress. N Engl J Med. 346: 1999–2001

    Article  PubMed  Google Scholar 

  • Stein CJ, Colditz GA, 2004, The epidemic of obesity. J Clin Endocrinol Metab. 89: 2522–2525

    Article  PubMed  CAS  Google Scholar 

  • Tahmasebi M, Puddefoot JR, Inwang ER, et al 1999, The tissue renin-angiotensin system in human pancreas. J Endocrinol. 161: 317–322

    Article  PubMed  CAS  Google Scholar 

  • The DREAM Trial Investigators, 2006, Effect of ramipril on the incidence of diabetes. N Engl J Med. 355: 1551–62

    Google Scholar 

  • Tikellis C, Cooper ME, Thomas MC, 2006, Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes. Int J Biochem Cell Biol. 38: 737–51

    Article  PubMed  CAS  Google Scholar 

  • Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ, 2000, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol. Chem. 275: 33238–33243

    Article  PubMed  CAS  Google Scholar 

  • Tsutsumi Y, Matsubara H, Masaki H, et al 1999, Angiotensin II type 2 receptor overexpression activates the vascular kynin system and causes vasodilatation. J Clin Invest. 104: 925–935

    Article  PubMed  CAS  Google Scholar 

  • Tuck ML, Sowers J, Dornfield L, Kledzik G, Maxwell M, 1981, The effect of weight reduction on blood pressure plasma renin activity and aldosterone levels in obese patients. N Eng J Med. 304: 930–933

    Article  CAS  Google Scholar 

  • Ushio-Fukai M, Alexander W, 2004, Reactive oxygen species as mediators of angiogenesis signaling: Role of NADPH oxidase. Mol Cell Biochem 264: 85–97

    Article  PubMed  CAS  Google Scholar 

  • Ushio-Fukai M, Tabg Y, Fukai T, et al 2002, Novel role of gp91phox containing NADPH oxidase in vascular endothelial growth factor induced signaling and angiogenesis. Circ Res. 91: 1160–1167

    Article  PubMed  CAS  Google Scholar 

  • Van HV, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P, 2000, Increased adipose angiotensinogen gene expression in human obesity. Obes Res. 8: 337–341

    Google Scholar 

  • Vidotti, DB, Casarinin DE, Cristovam PC, Leite CA, Boim MA, 2004, High glucose concentration stimulates renin activity and angiotensin II generation in mesangial cells. Am J Physiol Renal Physiol. 286: F1039–F1045

    Article  PubMed  CAS  Google Scholar 

  • Wang HD, Hope SK, Du Y, Quinn MT, Cayatte AJ, Cohen RA, 1999, Paracrine role of adventitial superoxide anion in spontaneous tone in the isolated rat aorta in angiotensin II – induced hypertension. Hypertension. 33: 1225–1232

    PubMed  CAS  Google Scholar 

  • Watanabe, T, Thomas A, Barker CB, 2005, Angiotensin II and the endothelium: Diverse signals and effects. Hypertension. 45: 163–169

    Article  PubMed  CAS  Google Scholar 

  • Yusuf S, Ostergren JB Gerstein HC, et al 2005, Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity Program Investigators. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation. 112: 48–53

    Article  PubMed  CAS  Google Scholar 

  • Zuo L Ushio-Fukai M, Hilenski LL, Alexander RW, 2004, Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling. Arterioscler Thromb Vasc Biol. 24: 1223–1228

    Article  PubMed  CAS  Google Scholar 

  • Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, Alexander RW, 2005, Caveolin 1 is Essential for Activation of Rac-1 and NADPH oxidase After Angiotensin II Type 1 receptor stimulation in Vascular Smooth Muscle Cells: Role in Redox Signaling and Vascular Hyperthophy. Arterioscler Thromb Vasc Biol. 25: 1824–1830

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Missouri-Columbia, Columbia, MO65212, USA

    Guido Lastra, Camila Manrique & James R. Sowers

Authors
  1. Guido Lastra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Camila Manrique
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James R. Sowers
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physiology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China

    Po Sing Leung PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer

About this chapter

Cite this chapter

Lastra, G., Manrique, C., Sowers, J.R. (2007). Renin-Angiotensin System Proteases and the Cardiometabolic Syndrome: Pathophysiological, Clinical and Therapeutic Implications. In: Leung, P.S. (eds) Frontiers in Research of the Renin-Angiotensin System on Human Disease. Proteases in Biology and Disease, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6372-5_5

Download citation

Publish with us

Policies and ethics

Search

Navigation